Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor- Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors br Article

sustainable development goals

publication date

  • August 1, 2022

webpage

published in

start page

  • 932

end page

  • 946

volume

  • 10

issue

  • 8